Vice President Antibody Engineering (m/w/d)

DISCO Pharmaceuticals GmbH

Zürich

Híbrido

CHF 260.000 - 360.000

Jornada completa

Hace 9 días
Generador de candidaturas

Consigue una respuesta de este empleador — un currículum y una carta de presentación adaptados exactamente a lo que busca para contratar.

Supera los filtros ATS

Ventajas ofrecidas por este puesto de trabajo

Long-term career prospects
Competitive compensation
30 days annual leave
Autonomy in research direction
Collaborative international culture

Descripción de la vacante

DISCO Pharmaceuticals GmbH in Schlieren, Switzerland, seeks an experienced VP Antibody Engineering to lead and expand antibody and protein engineering efforts, advancing multispecific T-cell engager programs from discovery to candidate nomination. You will shape architecture, driving innovation and collaboration across biology, translational sciences, and CMC.

We offer a long-term leadership role with substantial autonomy, a competitive package, and a culture that values scientific excellence,

Formación

  • PhD in Biochemistry, Molecular Biology, Protein Engineering, Immunology, Chemistry or related field.
  • 14+ years of industry biologics discovery and development experience with leadership.
  • Proven track record advancing multispecific antibody and T-cell engager programs.

Responsabilidades

  • Lead antibody and protein engineering with multispecific T-cell engager focus.
  • Define lead identification and optimization strategies from discovery to nomination.
  • Build and mentor high-performing, cross-functional teams.
  • Collaborate with Discovery, Translational Sciences, CMC and Development to advance programs.
  • Represent DISCO externally through publications and conferences.

Conocimientos

Antibody engineering
Leadership
Biologics development
Cross-functional collaboration
Strategic thinking

Educación

PhD in Biochemistry/Immunology

Descripción del empleo

DISCO Pharmaceuticals is an emerging biotechnology company with operations in Cologne, Germany, and Schlieren, Switzerland. We leverage a proprietary mass spectrometry-based technology platform to decode the molecular architecture of the cancer cell surface. By integrating expertise in cell biology, biochemistry, and computational analytics, we identify functionally relevant protein communities and novel therapeutic targets. Our mission is to develop innovative therapies for diseases with high unmet medical need, including cancer, and to translate new biological insights into meaningful clinical applications.

POSITION

We are seeking an experienced VP Antibody Engineering to lead and expand our antibody and protein engineering capabilities and drive the discovery of next-generation multispecific T-cell-engager therapeutics. This individual will play a critical role in shaping the design, optimization, and advancement of our biologics pipeline by providing scientific and strategic leadership across antibody discovery, engineering, and candidate selection. As a key member of the scientific leadership team, you will build and lead a high-performing antibody engineering organization, oversee the progression of multispecific TCE programs from concept to development candidate nomination, and collaborate closely with Discovery, Translational Sciences, CMC, and Executive Leadership to establish innovative therapeutic approaches for patients with cancer. The role is based in Schlieren (ZH), Switzerland, and involves occasional business travel.

RESPONSIBILITIES
  • Building, leading, and continuously expanding DISCO's antibody and protein engineering capabilitieswith a strategic focus on multispecific T-cell engager therapeutics, ensuring scientific excellence from discovery through clinical candidate nomination.
  • Providing scientific and organizational leadership, building a team and fostering a collaborative, innovative, and results-oriented culture while supporting the growth and development of team members.
  • Defining and driving lead identification and optimization strategies, including antibody discovery, affinity maturation, humanization, developability assessment, immunogenicity risk mitigation, and manufacturability optimization.
  • Serving as the scientific leader for antibody engineering across the portfolio, providing strategic guidance on epitope selection, molecular architecture, therapeutic format selection, and structure-function relationships.
  • Leading the design and optimization of multispecific antibodies and T-cell engagers, with the goal of achieving differentiated efficacy, safety, pharmacokinetic, and developability profiles.
  • Establishing innovative technology platforms and engineering workflows, including computational approaches, library design, screening strategies, and data-driven molecule optimization methods.
  • Working closely with cross-functional teams, including Discovery Biology, Translational Sciences, CMC, Clinical Development, and Project Leadership, to advance programs from target validation through candidate nomination.
  • Managing external collaborations, technology partnerships, and CRO activities, ensuring high-quality deliverables, efficient execution, and alignment with program objectives.
  • Contributing to portfolio strategy, intellectual property generation, and business development activities, including the evaluation of external technologies and partnership opportunities.
  • Representing DISCO externally through scientific publications, conference presentations, and interactions with key opinion leaders and strategic partners.
YOUR PROFILE
Qualification

You hold a PhD in Biochemistry, Molecular Biology, Protein Engineering, Immunology, Chemistry, or a related life science discipline. In addition, you bring more than 14 years of relevant industry experience in biologics discovery and development, including significant leadership responsibilities within biotechnology or pharmaceutical organizations. You have a strong track record of advancing multispecific antibody and T-cell engager programs from discovery through development candidate nomination and are passionate about translating scientific innovation into transformative therapies for patients with cancer.

Experience

We expect competencies in the following areas:

  • Recognized expertise in antibody and protein engineering, including design and optimization of monoclonal, bispecific, and multispecific antibodies, T-cell engagers, antibody fragments, and other complex biologics.
  • Proven track record of progressing biologics programs from discovery through candidate selection, ideally including multispecific T-cell engager therapeutics and immuno-oncology applications.
  • Extensive experience in antibody discovery technologies, including library design, screening strategies, affinity maturation, humanization, developability optimization, and immunogenicity assessment.
  • Deep understanding of molecular design principlesaffecting potency, selectivity, safety, pharmacokinetics, manufacturability, and overall developability of therapeutic proteins.
  • Strong leadership capabilitieswith demonstrated success building, mentoring, and leading high-performing scientific teams in cross-functional and matrix organizations.
  • Experience working across Discovery, Translational Sciences, CMC, and Development functionsto successfully advance innovative therapeutic programs.
  • Excellent communication and stakeholder management skills, including presentation of complex scientific concepts to executive leadership, external partners, and scientific audiences.
  • A strategic, entrepreneurial, and solution-oriented mindset, combined with the ability to operate effectively in a fast-paced and highly collaborative biotechnology environment.
WE OFFER
  • Long-term career prospects through a permanent employment contract with a future-oriented company
  • Competitive compensation and attractive employment conditions
  • 30 days of annual leave as well as a work environment that supports professional development
  • Exciting responsibilities at the interface of research and laboratory practice, offering a high degree of autonomy and opportunities to make an impact
  • A collaborative, international corporate culture with flat hierarchies, short decision-making processes, and regular team activities
Consigue la evaluación confidencial y gratuita de tu currículum.

o arrastra y suelta tu archivo aquí

Similar jobs

Puestos de trabajo similares que vale la pena comparar

Vice President Discovery (m/w/d)
Vice President Discovery (m/w/d)

DISCO Pharmaceuticals GmbH • Zürich

Híbrido
CHF 260.000 - 360.000
Long-term career prospects
30 days annual leave
Competitive compensation
+1
Vice President Discovery
Vice President Discovery

DISCO Pharmaceuticals Swiss GmbH • Schlieren

Presencial
CHF 260.000 - 380.000
Career growth
Competitive compensation
30 days annual leave
+2
VP Antibody Engineering & Multispecifics Leader
VP Antibody Engineering & Multispecifics Leader

DISCO Pharmaceuticals GmbH • Zürich

Híbrido
CHF 260.000 - 360.000
Long-term career prospects
Competitive compensation
30 days annual leave
+2
Project Lead – Target Validation and Drug Discovery
Project Lead – Target Validation and Drug Discovery

DISCO Pharmaceuticals Swiss GmbH • Schlieren

Híbrido
CHF 140.000 - 190.000
Langfristige Karriereperspektiven
Wettbewerbsfähige Vergütung
30 Tage Jahresurlaub
+1
Associate Director / Director, Biology – Targeted Protein Degradation
Associate Director / Director, Biology – Targeted Protein Degradation

Ridgeline Discovery • Basel

Presencial
CHF 180.000 - 260.000
Prime Location
Commuter Benefits
Flexible Working
+7
Associate Director / Director, Biology – Targeted Protein Degradation
Associate Director / Director, Biology – Targeted Protein Degradation

Ridgeline Discovery GmbH • Basel

Híbrido
CHF 180.000 - 240.000
Prime Location Basel
Commuter Benefits
Flexible Working
+2
Head of Discovery & Immuno-Oncology Platforms
Head of Discovery & Immuno-Oncology Platforms

DISCO Pharmaceuticals GmbH • Zürich

Híbrido
CHF 260.000 - 360.000
Long-term career prospects
30 days annual leave
Competitive compensation
+1
INDUSTRIAL PHD CANDIDATE CANCER IMMUNOTHERAPY / BISPECIFIC ANTIBODIES (BIOLOGY GROUP)
INDUSTRIAL PHD CANDIDATE CANCER IMMUNOTHERAPY / BISPECIFIC ANTIBODIES (BIOLOGY GROUP)

Philochem AG • Zürich

Presencial
CHF 60.000 - 80.000
Industrial PhD program
Cutting-edge infrastructure
Mentoring from industry and academia
+2
Principal Scientist - Discovery Oncology
Principal Scientist - Discovery Oncology

F. Hoffmann-La Roche AG • Basel

Presencial
CHF 150.000 - 190.000
Senior Project Lead, Target Validation & Immuno-Oncology
Senior Project Lead, Target Validation & Immuno-Oncology

DISCO Pharmaceuticals Swiss GmbH • Schlieren

Híbrido
CHF 140.000 - 190.000
Langfristige Karriereperspektiven
Wettbewerbsfähige Vergütung
30 Tage Jahresurlaub
+1